Add Yahoo as a preferred source to see more of our stories on Google. SolStock/Getty This month, the FDA approved a nasal spray version of the drug epinephrine, a potentially ground-breaking ...
Add Yahoo as a preferred source to see more of our stories on Google. The FDA approved Neffy, the first nasal epinephrine drug for treating severe allergies, pictured here in a screenshot from a ...
NEW NASAL SPRAY, NOW APPROVED TO SAVE LIVES AFTER A SEVERE ALLERGIC REACTION. HERE TO TELL US MORE IS DOCTOR ALI RAJA, DEPUTY CHAIR OF THE DEPARTMENT OF EMERGENCY MEDICINE AT MASS GENERAL. DOCTOR RAJA ...
Credit: ARS Pharma. Neffy is supplied as a single-dose (2mg of epinephrine) nasal spray that is administered into 1 nostril. With regard to cardiovascular effects, increases in blood pressure and ...
The nasal spray, marked as neffy, is intended as an emergency treatment for severe allergic reactions. Neffy is the first needle-free alternative to shots like EpiPen. The FDA said it approved the ...
Those at risk of a severe allergic reaction always have handy an EpiPen just in case. But soon their life might be saved by a spray in the nose rather than a needle to the thigh. Last week the FDA ...
Credit: ARS Pharmaceuticals. Neffy is indicated for adult and pediatric patients weighing at least 30kg. It is recommended that patients be prescribed and have immediate access to 2 neffy nasal sprays ...
neffy is the first epinephrine product approved for use out of a hospital setting in China for adults and children (>30 kg) living with severe allergic reactions Pediatrix Therapeutics, which has a ...
On 9 August, US health officials approved the first nasal spray to treat allergic reactions from drugmaker ARS Pharmaceuticals Inc, an alternative to injectable allergy medications like EpiPen. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results